SERB Pharmaceuticals is a European pharmaceutical company and a pivotal player in the research, development, manufacturing, supply, and distribution of crisis-related CBRN medical countermeasures. They have built the broadest antidote portfolio in the world, including countermeasures for nerve agents, cyanide, heavy metal poisoning, and radiation; effectively addressing a wide spectrum of major risks for public health.
More info www.serb.com